FDA Inspection 1037443 — Zhimin (NMI) Shao
The FDA completed an inspection of Zhimin (NMI) Shao on Dec 8, 2017 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shanghai (China)
Additional details
Clinical Investigator (CI)